38078820	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
of	O	O
the	O	O
Thorax	O	O
,	O	O
11/14/2008	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
A	O	O
62-year-old	O	O
male	O	O
with	O	O
history	O	O
of	O	O
supracricoid	O	O
carcinoma	O	O
.	O	O
Findings	O	O
:	O	O
CT	O	O
scan	O	O
of	O	O
the	O	O
chest	O	O
was	O	O
obtained	O	O
after	O	O
the	O	O
administration	O	O
of	O	O
intravenous	O	O
contrast	O	O
.	O	O
No	O	O
prior	O	O
chest	O	O
CTs	O	O
are	O	O
available	O	O
for	O	O
comparison	O	O
.	O	O
Correlation	O	O
is	O	O
made	O	O
with	O	O
the	O	O
previously	O	O
performed	O	O
PET/CTs	O	O
.	O	O
No	O	O
discrete	O	O
pulmonary	O	O
nodules	O	O
are	O	O
identified	O	O
that	O	O
are	O	O
suspicious	O	O
for	O	O
metastatic	O	O
disease	O	O
.	O	O
There	O	O
are	O	O
mediastinal	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
hilar	3_Yellow_Days	3_Yellow_Days
lymph	3_Yellow_Days	3_Yellow_Days
nodes	3_Yellow_Days	3_Yellow_Days
which	3_Yellow_Days	O
are	3_Yellow_Days	O
prominent	3_Yellow_Days	O
but	3_Yellow_Days	O
stable	3_Yellow_Days	O
dating	3_Yellow_Days	O
back	O	O
to	O	O
May	O	O
of	O	O
this	O	O
year	O	O
.	O	O
The	O	O
right	O	O
hilar	O	O
node	O	O
measures	O	O
approximately	O	O
1.8	O	O
x	O	O
2.2	O	O
cm	O	O
.	O	O
A	O	O
mediastinal	O	O
lymph	O	O
node	O	O
measures	O	O
1.1	O	O
x	O	O
1.1	O	O
cm	O	O
.	O	O
These	3_Yellow_Days	O
can	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
followed	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
exclude	3_Yellow_Days	3_Yellow_Days
metastatic	3_Yellow_Days	3_Yellow_Days
disease	3_Yellow_Days	3_Yellow_Days
.	O	O
There	O	O
is	O	O
a	O	O
button	O	O
in	O	O
place	O	O
.	O	O
No	O	O
pleural	O	O
or	O	O
pericardial	O	O
effusion	O	O
is	O	O
seen	O	O
.	O	O
No	O	O
hepatic	O	O
lesions	O	O
are	O	O
identified	O	O
.	O	O
The	O	O
spleen	O	O
contains	O	O
granulomas	O	O
.	O	O
There	O	O
is	O	O
slight	O	O
nodularity	O	O
of	O	O
the	O	O
left	O	O
adrenal	O	O
gland	O	O
.	O	O
IMPRESSION	O	O
:	O	O
No	O	O
definite	O	O
evidence	O	O
of	O	O
metastatic	O	O
disease	O	O
.	O	O
Mediastinal	3_Yellow_Days	O
and	3_Yellow_Days	O
hilar	3_Yellow_Days	O
lymph	3_Yellow_Days	O
nodes	3_Yellow_Days	O
have	3_Yellow_Days	O
remained	3_Yellow_Days	O
stable	3_Yellow_Days	O
dating	O	O
back	O	O
to	O	O
May	O	3_Yellow_Days
and	O	O
can	O	O
be	O	O
followed	O	O
on	O	O
subsequent	O	O
exams	O	O
or	O	O
PET/CT	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
05/07/2007	O	O
ES	O	O
>	O	O
<	O	O
REPOCT	O	O
of	O	O
the	O	O
chest	O	O
without	O	O
contrast	O	O
media	O	O
as	O	O
per	O	O
coronary	O	O
calcification	O	O
protocol	O	O
.	O	O
CT	O	O
scan	O	O
of	O	O
the	O	O
heart	O	O
was	O	O
done	O	O
to	O	O
evaluate	O	O
for	O	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
calcification	3_Yellow_Days	3_Yellow_Days
.	O	O
The	O	O
examination	O	O
is	O	O
positive	O	O
and	O	O
shows	O	O
definite	O	O
calcium	3_Yellow_Days	O
deposits	3_Yellow_Days	O
which	O	O
are	O	O
diagnostic	O	O
of	O	O
atherosclerotic	O	O
disease	O	O
.	O	O
The	O	O
calcium	3_Yellow_Days	O
score	3_Yellow_Days	O
is	3_Yellow_Days	O
5	3_Yellow_Days	O
.	O	O
This	O	O
score	O	O
places	O	O
this	O	O
patient	O	O
in	O	O
the	O	O
42	O	O
percentile	O	O
for	O	O
quantity	O	O
of	O	O
calcification	O	O
for	O	O
her	O	O
age	O	O
and	O	O
gender	O	O
group	O	O
when	O	O
compared	O	O
to	O	O
our	O	O
age	O	O
and	O	O
gender	O	O
matched	O	O
control	O	O
group	O	O
.	O	O
There	O	O
is	O	O
calcification	O	O
at	O	O
the	O	O
proximal	3_Yellow_Days	O
left	3_Yellow_Days	O
anterior	3_Yellow_Days	O
descending	3_Yellow_Days	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
.	O	O
Remainder	O	O
is	O	O
negative	O	O
.	O	O
39021337	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
scan	O	O
of	O	O
the	O	O
chest	O	O
,	O	O
08/07/2009	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
Breast	O	O
carcinoma	O	O
.	O	O
Findings	O	O
:	O	O
1	O	O
.	O	O
Non	O	O
intravenous	O	O
contrast-enhanced	O	O
scans	O	O
have	O	O
been	O	O
obtained	O	O
and	O	O
there	O	O
is	O	O
a	O	O
left	1_Red_Minutes	O
pleural	1_Red_Minutes	O
effusion	1_Red_Minutes	O
with	1_Red_Minutes	O
foci	1_Red_Minutes	O
of	1_Red_Minutes	O
loculation	1_Red_Minutes	O
with	1_Red_Minutes	O
some	1_Red_Minutes	O
associated	1_Red_Minutes	O
focal	1_Red_Minutes	O
areas	1_Red_Minutes	O
of	1_Red_Minutes	O
pleural	1_Red_Minutes	O
thickening	1_Red_Minutes	O
in	O	O
the	O	O
region	O	O
of	O	O
the	O	O
upper	O	O
lobe	O	O
of	O	O
the	O	O
left	O	O
lung	O	O
,	O	O
a	O	O
left	O	O
chest	O	O
tube	O	O
is	O	O
noted	O	O
in	O	O
place	O	O
,	O	O
findings	1_Red_Minutes	O
can	1_Red_Minutes	O
be	1_Red_Minutes	O
clinically	1_Red_Minutes	O
correlated	1_Red_Minutes	O
for	1_Red_Minutes	O
any	1_Red_Minutes	O
malignant	1_Red_Minutes	O
pleural	1_Red_Minutes	O
effusion	1_Red_Minutes	O
,	O	O
this	O	O
fluid	O	O
was	O	O
not	O	O
noted	O	O
on	O	O
an	O	O
outside	O	O
hospital	O	O
study	O	O
obtained	O	O
on	O	O
04/15/2005	O	O
.	O	O
2	O	O
.	O	O
There	O	O
is	O	O
no	O	O
evidence	O	O
of	O	O
any	O	O
confluent	O	O
acute	O	O
lung	O	O
infiltrates	O	O
.	O	O
Some	O	O
linear	O	O
subsegmental	O	O
atelectatic	O	O
foci	O	O
are	O	O
noted	O	O
in	O	O
the	O	O
left	O	O
lung	O	O
.	O	O
There	O	O
is	O	O
no	O	O
evidence	O	O
of	O	O
any	O	O
lung	O	O
nodules	O	O
.	O	O
Some	3_Yellow_Days	O
focal	3_Yellow_Days	O
areas	3_Yellow_Days	O
of	3_Yellow_Days	O
pleural	3_Yellow_Days	O
thickening	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
chest	3_Yellow_Days	O
are	O	O
identified	O	O
and	O	O
this	O	O
may	3_Yellow_Days	O
be	3_Yellow_Days	O
related	3_Yellow_Days	O
to	3_Yellow_Days	O
chronic	3_Yellow_Days	3_Yellow_Days
inflammatory	3_Yellow_Days	3_Yellow_Days
changes	3_Yellow_Days	3_Yellow_Days
.	O	O
3	O	O
.	O	O
Some	1_Red_Minutes	O
sclerotic	1_Red_Minutes	O
foci	1_Red_Minutes	O
are	1_Red_Minutes	O
identified	1_Red_Minutes	O
in	1_Red_Minutes	3_Yellow_Days
some	1_Red_Minutes	3_Yellow_Days
of	1_Red_Minutes	3_Yellow_Days
the	1_Red_Minutes	3_Yellow_Days
vertebral	1_Red_Minutes	3_Yellow_Days
bodies	1_Red_Minutes	3_Yellow_Days
and	1_Red_Minutes	O
the	1_Red_Minutes	O
ribs	1_Red_Minutes	O
and	1_Red_Minutes	O
in	1_Red_Minutes	O
the	1_Red_Minutes	O
sternum	1_Red_Minutes	O
,	1_Red_Minutes	O
findings	1_Red_Minutes	O
compatible	1_Red_Minutes	O
with	1_Red_Minutes	O
metastatic	1_Red_Minutes	O
foci	1_Red_Minutes	O
-LRB-	O	O
this	O	O
can	O	O
not	O	O
be	O	O
compared	O	O
to	O	O
the	O	O
outside	O	O
hospital	O	O
study	O	O
of	O	O
04/15/2005	O	O
secondary	O	O
to	O	O
technical	O	O
differences	O	O
-RRB-	O	O
.	O	O
Additionally	O	O
,	O	O
there	O	O
is	O	O
compression	1_Red_Minutes	O
with	1_Red_Minutes	O
sclerosis	1_Red_Minutes	O
superimposed	1_Red_Minutes	O
on	1_Red_Minutes	O
degenerative	1_Red_Minutes	O
spondylosis	1_Red_Minutes	O
in	1_Red_Minutes	O
the	1_Red_Minutes	O
seventh	1_Red_Minutes	O
dorsal	1_Red_Minutes	O
vertebral	1_Red_Minutes	O
body	1_Red_Minutes	O
and	O	O
this	O	O
may	O	O
be	O	O
related	O	O
to	O	O
metastasis	1_Red_Minutes	3_Yellow_Days
superimposed	1_Red_Minutes	O
on	1_Red_Minutes	O
degenerative	1_Red_Minutes	O
changes	1_Red_Minutes	O
.	O	O
4	O	O
.	O	O
There	O	O
is	O	O
a	1_Red_Minutes	O
soft	1_Red_Minutes	O
tissue	1_Red_Minutes	O
attenuation	1_Red_Minutes	O
focus	1_Red_Minutes	O
in	1_Red_Minutes	O
the	1_Red_Minutes	O
midline	1_Red_Minutes	O
of	1_Red_Minutes	O
the	1_Red_Minutes	O
lower	1_Red_Minutes	O
chest	1_Red_Minutes	O
in	O	O
the	O	O
anterior	O	O
chest	O	O
wall	O	O
region	O	O
abutting	O	O
the	O	O
sternal	O	O
region	O	O
with	O	O
slight	O	O
associated	O	O
sternal	O	3_Yellow_Days
sclerosis	O	3_Yellow_Days
-LRB-	O	O
series	O	O
2	O	O
,	O	O
images	O	O
32	O	O
,	O	O
30	O	O
-RRB-	O	O
,	O	O
this	O	O
measures	O	O
approximately	O	O
2.4	O	O
x	O	O
1.6	O	O
cm	O	O
in	O	O
dimension	O	O
and	O	O
is	1_Red_Minutes	O
compatible	1_Red_Minutes	O
with	1_Red_Minutes	O
recurrent	1_Red_Minutes	O
focus	1_Red_Minutes	O
.	O	O
This	O	O
was	O	O
not	O	O
noted	O	O
on	O	O
the	O	O
study	O	O
of	O	O
2005	O	O
,	O	O
a	O	O
focal	O	O
opacity	O	O
in	O	O
the	O	O
left	O	O
lower	O	O
anterior	O	O
chest	O	O
wall	O	O
region	O	O
-LRB-	O	O
series	O	O
2	O	O
,	O	O
image	O	O
39	O	O
-RRB-	O	O
which	O	O
may	O	O
be	O	O
related	O	O
to	O	O
postsurgical	O	O
change	O	O
is	O	O
stable	O	O
since	O	O
the	O	O
study	O	O
of	O	O
2005	O	O
.	O	O
Postsurgical	O	O
changes	O	O
are	O	O
noted	O	O
in	O	O
the	O	O
axillary	O	O
and	O	O
breast	O	O
regions	O	O
and	O	O
some	O	3_Yellow_Days
small	O	3_Yellow_Days
axillary	O	3_Yellow_Days
nodes	O	3_Yellow_Days
possibly	O	3_Yellow_Days
reactive	O	3_Yellow_Days
in	O	O
nature	O	O
are	O	O
identified	O	O
.	O	O
There	O	O
may	O	O
be	O	O
a	O	O
tiny	3_Yellow_Days	O
amount	3_Yellow_Days	O
of	3_Yellow_Days	O
air	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
mediastinum	3_Yellow_Days	3_Yellow_Days
-LRB-	O	O
series	O	O
2	O	O
,	O	O
image	O	O
29	O	O
-RRB-	O	O
.	O	O
IMPRESSION	O	O
:	O	O
Left	1_Red_Minutes	O
pleural	1_Red_Minutes	O
effusion	1_Red_Minutes	O
with	1_Red_Minutes	O
loculation	1_Red_Minutes	O
and	1_Red_Minutes	O
this	1_Red_Minutes	O
can	1_Red_Minutes	O
be	1_Red_Minutes	O
clinically	1_Red_Minutes	O
correlated	1_Red_Minutes	O
for	1_Red_Minutes	O
malignant	1_Red_Minutes	O
effusion	1_Red_Minutes	O
,	O	O
no	O	O
lung	O	O
nodules	O	O
,	O	O
soft	1_Red_Minutes	O
tissue	1_Red_Minutes	O
in	1_Red_Minutes	O
the	1_Red_Minutes	O
anterior	1_Red_Minutes	O
chest	1_Red_Minutes	O
wall	1_Red_Minutes	O
region	O	O
close	O	O
to	O	O
the	O	O
midline	O	O
as	O	O
described	O	O
,	O	O
compatible	1_Red_Minutes	O
with	1_Red_Minutes	O
recurrence	1_Red_Minutes	O
.	O	O
Some	O	O
small	3_Yellow_Days	O
nonspecific	3_Yellow_Days	O
mediastinal	3_Yellow_Days	O
nodes	3_Yellow_Days	O
without	3_Yellow_Days	O
significant	3_Yellow_Days	O
lymphadenopathy	3_Yellow_Days	O
,	O	O
skeletal	1_Red_Minutes	O
metastases	1_Red_Minutes	O
as	1_Red_Minutes	O
described	1_Red_Minutes	O
.	O	O
Study	O	O
has	O	O
been	O	O
obtained	O	O
without	O	O
intravenous	O	O
contrast	O	O
enhancement	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MEDIASTINUM	O	O
PLEURA	O	O
71260	O	O
CT	O	O
CHEST	O	O
w	O	O
CT05/07/2007	O	O
/	O	O
EXAM_CODES	O	O
>	O	O
<	O	O
REPOEnhanced	O	O
chest	O	O
CT	O	O
with	O	O
additional	O	O
thin	O	O
section	O	O
reconstructed	O	O
images	O	O
is	O	O
compared	O	O
to	O	O
CT	O	O
of	O	O
3-26-07	O	O
.	O	O
No	3_Yellow_Days	O
significant	3_Yellow_Days	O
change	3_Yellow_Days	O
in	O	O
the	O	O
mild	3_Yellow_Days	O
mediastinal	3_Yellow_Days	O
and	3_Yellow_Days	O
mild	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
hilar	3_Yellow_Days	3_Yellow_Days
adenopathy	3_Yellow_Days	3_Yellow_Days
.	O	O
A	O	O
small	3_Yellow_Days	O
nodule	3_Yellow_Days	O
in	O	O
the	O	O
left	3_Yellow_Days	O
base	3_Yellow_Days	O
posteriorly	O	O
-LRB-	O	O
series	O	O
2	O	O
,	O	O
image	O	O
42	O	O
-RRB-	O	O
has	O	O
enlargedslightly	3_Yellow_Days	O
.	O	O
Numerous	O	O
other	O	O
very	O	3_Yellow_Days
small	O	3_Yellow_Days
bilateral	O	3_Yellow_Days
pulmonary	O	3_Yellow_Days
nodules	O	3_Yellow_Days
have	O	O
not	O	O
changed	O	O
appreciably	O	O
.	O	O
No	O	O
definite	O	O
new	O	O
nodules	O	O
.	O	O
Radiation	O	O
fibrosis	O	O
with	O	O
volume	O	O
loss	O	O
in	O	O
the	O	O
right	O	3_Yellow_Days
midlung	O	3_Yellow_Days
anteriorly	O	3_Yellow_Days
.	O	O
Stable	O	O
scattered	O	O
scarring	O	O
in	O	O
the	O	O
bases	O	O
.	O	O
Scattered	3_Yellow_Days	O
skeletal	3_Yellow_Days	O
metastases	3_Yellow_Days	O
,	O	O
a	O	O
few	O	O
of	O	O
which	O	O
are	O	O
slightly	O	O
more	O	O
prominent	O	O
.	O	O
Healing	3_Yellow_Days	O
pathologic	3_Yellow_Days	O
fractures	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
posterolateral	3_Yellow_Days	O
left	3_Yellow_Days	O
8th	3_Yellow_Days	O
and	3_Yellow_Days	O
9th	3_Yellow_Days	O
ribs	3_Yellow_Days	O
,	O	O
with	O	O
slightly	O	O
more	O	O
callus	O	O
formation	O	O
today	O	O
.	O	O
Mild	O	3_Yellow_Days
heterogeneous	O	3_Yellow_Days
enlargement	O	3_Yellow_Days
of	O	O
the	O	O
both	O	O
lobes	O	O
of	O	O
the	O	O
thyroid	O	O
gland	O	O
,	O	O
unchanged	O	3_Yellow_Days
.	O	O
Right	O	O
mastectomy	O	O
.	O	O
Small	O	O
esophageal	O	O
hiatal	O	O
hernia	O	O
.	O	O
Cholelithiasis	O	O
.	O	O
Stable	3_Yellow_Days	3_Yellow_Days
left	3_Yellow_Days	3_Yellow_Days
renal	3_Yellow_Days	3_Yellow_Days
calculus	3_Yellow_Days	3_Yellow_Days
.	O	O

